Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
130 hedge funds and large institutions have $937M invested in Tetraphase Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 18 reducing their positions, and 13 closing their positions.
262% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 13
200% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 18
35% more funds holding
Funds holding: 96 → 130 (+34)
13% more capital invested
Capital invested by funds: $830M → $937M (+$107M)
56% less call options, than puts
Call options by funds: $2.65M | Put options by funds: $6.03M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$28.3M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$22.7M |
| 3 |
HM
HealthCor Management
New York
|
+$17.5M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$16.6M |
| 5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$15.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$46.7M |
| 2 |
PC
PointState Capital
New York
|
-$31.8M |
| 3 |
IG
ING Group
Amsterdam,
Netherlands
|
-$26.1M |
| 4 |
Millennium Management
New York
|
-$11.8M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$10.1M |
TTPH Hedge Fund Activity: Q1 2015 in Review
130 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q1 2015, worth a combined $937M — up 13% from $830M a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new TTPH positions and 13 closed out — a net gain of 34 holders — while 54 added to existing stakes and 18 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $28.3M. The largest seller was Novo Holdings A/S, cutting an estimated $46.7M.
- 130 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q1 2015, up from 96 in Q4 2014.
- Funds reported $937M of Tetraphase Pharmaceuticals, Inc. stock for Q1 2015, up 13% quarter-over-quarter.
- 47 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q1 2015 and 13 closed out, a net change of +34 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q1 2015 was Wellington Management Group, an estimated $28.3M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q1 2015 was Novo Holdings A/S, an estimated $46.7M sold.
Based on aggregated 13F filings for Q1 2015.